INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,873,349 | +22.2% | 113,796 | +2.1% | 0.26% | +24.2% |
| Q2 2023 | $2,351,300 | +42.3% | 111,436 | +15.0% | 0.21% | +29.4% |
| Q1 2023 | $1,652,691 | -14.4% | 96,932 | +0.3% | 0.16% | -18.5% |
| Q4 2022 | $1,931,786 | -8.3% | 96,686 | -1.1% | 0.20% | -7.0% |
| Q3 2022 | $2,106,000 | +67.1% | 97,756 | +53.0% | 0.22% | +70.6% |
| Q2 2022 | $1,260,000 | -15.2% | 63,890 | +1.1% | 0.13% | -0.8% |
| Q1 2022 | $1,486,000 | -12.8% | 63,221 | +1.1% | 0.13% | -8.0% |
| Q4 2021 | $1,704,000 | +0.9% | 62,537 | +2.0% | 0.14% | -8.6% |
| Q3 2021 | $1,689,000 | -3.2% | 61,327 | +0.1% | 0.15% | -6.2% |
| Q2 2021 | $1,744,000 | +9.7% | 61,277 | +31.3% | 0.16% | +3.2% |
| Q1 2021 | $1,590,000 | +1.1% | 46,673 | -1.2% | 0.16% | -6.6% |
| Q4 2020 | $1,573,000 | +3.4% | 47,262 | -0.1% | 0.17% | -11.2% |
| Q3 2020 | $1,521,000 | +1.7% | 47,309 | -12.8% | 0.19% | +2.7% |
| Q2 2020 | $1,495,000 | – | 54,276 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |